Managers / Q2 2022 · view latest →
Nekton Capital Ltd.
CIK 0001884716 · 2 PORTMAN STREET, LONDON, X0, W1H 6DU · 44 20 3925 3300
Summary
Nekton Capital Ltd. reported $310M in U.S.-listed holdings across 17 positions for Q2 2022.
Its largest position, QGEN, represents 16.9% of the portfolio.
Compared with Q1 2022, the fund opened 10 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 84.9% · $264M
- ADR · 9.4% · $29M
- Other · 5.7% · $18M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VVVVALVOLINE INC | NEW | +804.2K | 804.2K | +$23M | $23M |
| YRIYAMANA GOLD INC | NEW | +3.70M | 3.70M | +$17M | $17M |
| GDDYGODADDY INC-A | NEW | +233.8K | 233.8K | +$16M | $16M |
| BABAALIBABA GRP-ADR | NEW | +108.0K | 108.0K | +$12M | $12M |
| BROOKFIELD ASS-A | NEW | +235.4K | 235.4K | +$10M | $10M |
| JDJD.COM INC-ADR | NEW | +160.2K | 160.2K | +$10M | $10M |
| EXPEEXPEDIA GROUP IN | NEW | +100.5K | 100.5K | +$10M | $10M |
| HORIZON THERAPEU | NEW | +88.8K | 88.8K | +$7M | $7M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | QGENQIAGEN NVhistory → | SHS NEW | 16.94% | $53M | 1.11M |
| 2 | TERMINIX GLOBAL | COM | 15.19% | $47M | 1.16M |
| 3 | ZBHZIMMER BIOMET HOhistory → | COM | 9.68% | $30M | 286.0K |
| 4 | MRVIMARAVAI LIFESC-Ahistory → | COM CL A | 8.21% | $25M | 896.5K |
| 5 | VVVVALVOLINE INChistory → | COM | 7.47% | $23M | 804.2K |
| 6 | YRIYAMANA GOLD INChistory → | COM | 5.54% | $17M | 3.70M |
| 7 | EHCENCOMPASS HEALTHhistory → | COM | 5.47% | $17M | 302.8K |
| 8 | GDDYGODADDY INC-Ahistory → | CL A | 5.24% | $16M | 233.8K |
| 9 | CNHCNH INDUSTRIAL Nhistory → | SHS | 5.13% | $16M | 1.37M |
| 10 | BABAALIBABA GRP-ADRhistory → | SPONSORED ADS | 3.96% | $12M | 108.0K |
| 11 | BROOKFIELD ASS-A | CL A LTD VT SH | 3.37% | $10M | 235.4K |
| 12 | JDJD.COM INC-ADRhistory → | SPON ADR CL A | 3.31% | $10M | 160.2K |
| 13 | EXPEEXPEDIA GROUP INhistory → | COM NEW | 3.07% | $10M | 100.5K |
| 14 | HORIZON THERAPEU | SHS | 2.28% | $7M | 88.8K |
| 15 | HTHTH WORLD GROU-ADRhistory → | SPONSORED ADS | 2.16% | $7M | 175.7K |
| 16 | WBDWARNER BROS DISChistory → | COM SER A | 2.12% | $7M | 489.1K |
| 17 | NUVASIVE INC | COM | 0.85% | $3M | 53.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $49M | 18 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $49M | 13 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $36M | 9 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $38M | 7 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $22M | 4 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $220M | 14 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $429M | 16 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $435M | 13 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $631M | 16 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $610M | 15 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $599M | 15 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $443M | 18 | Feb 15, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2022 | $367M | 17 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $310M | 17 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $406M | 13 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $165M | 14 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.